Megan E. Ermler

Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin

Madhusudan Rajendran, Raffael Nachbagauer, Megan E. Ermler et al. · mBio · 2017 · 161 citations · Full text

Life Sciences, Immunology, Infectious Diseases +11

Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial

David I. Bernstein, Jeffrey T. Guptill, Abdollah Naficy et al. · The Lancet Infectious Diseases · 2019 · 140 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse Model

Megan E. Ermler, Ericka Kirkpatrick, Weina Sun et al. · Journal of Virology · 2017 · 89 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Development of Influenza B Universal Vaccine Candidates Using the “Mosaic” Hemagglutinin Approach

Weina Sun, Ericka Kirkpatrick, Megan E. Ermler et al. · Journal of Virology · 2019 · 71 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Influenza A Viruses Expressing Intra- or Intergroup Chimeric Hemagglutinins

Chi-Jene Chen, Megan E. Ermler, Gene S. Tan et al. · Journal of Virology · 2016 · 49 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +11